RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Gertraud Maskarinec to Prostatic Neoplasms

This is a "connection" page, showing publications Gertraud Maskarinec has written about Prostatic Neoplasms.
Connection Strength

0.422
  1. Harmon BE, Little MA, Woekel ED, Ettienne R, Long CR, Wilkens LR, Le Marchand L, Henderson BE, Kolonel LN, Maskarinec G. Ethnic differences and predictors of colonoscopy, prostate-specific antigen, and mammography screening participation in the multiethnic cohort. Cancer Epidemiol. 2014 Apr; 38(2):162-7.
    View in: PubMed
    Score: 0.269
  2. Haraldsdottir A, Steingrimsdottir L, Maskarinec G, Adami HO, Aspelund T, Valdimarsdottir UA, Bjarnason R, Thorsdottir I, Halldorsson TI, Gunnarsdottir I, Tryggvadottir L, Gudnason V, Birgisdottir BE, Torfadottir JE. Growth Rate in Childhood and Adolescence and the Risk of Breast and Prostate Cancer: A Population-Based Study. Am J Epidemiol. 2022 01 24; 191(2):320-330.
    View in: PubMed
    Score: 0.116
  3. Singh H, Maskarinec G, Shumay DM. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer. Integr Cancer Ther. 2005 Jun; 4(2):187-94.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support